Complete Immunity Preemption

Text Size

Complete Immunity Preemption 

A “Get Out of Jail Free” Card for Corporations

In the News

"The Supreme Court dealt a defeat to the pharmaceutical industry and the Bush administration Wednesday, ruling that federal approval of a prescription drug does not provide a shield against lawsuits from injured patients."

"Suprume Court Rules Patients can Sue Drug Makers"

LA Times, 3/5/09

"Influential members of Congress plan to introduce a bill soon that would supersede last year’s Supreme Court device ruling, their aides say. If that legislation became law, injured people or their survivors would have the same right to sue device makers that the Supreme Court on Wednesday gave to people claiming injury or death from unsafe drugs."

"Drug Ruling Puts Devices in Spotlight"

New York Times, 3/5/09

"Under this ruling, an injured person can still get justice," said Ed Blizzard

"High court upholds right to sue drugmakers"

Philadelphia Inquirer, 3/5/09

 
Read how complete immunity preemption hurts consumers like Diana Levine»

 

 

The United States Supreme Court and Congress are facing critical issues that—depending on how they are resolved—could provide negligent corporations complete immunity from lawsuits.

It’s called federal preemption, and it refers to situations in which federal regulation trumps state law. And, perhaps most surprising, Americans and many policymakers have never heard of it. When viewed through the context of unsafe products, preemption of state law means complete immunity from lawsuits for corporations and a full escape from accountability when they have knowingly injured and endangered Americans. The civil justice system offers corporations a powerful incentive to make their products safer. All people should have a fair chance to receive justice through the legal system when they are injured by the negligence or misconduct of others—even when it means taking on the most powerful corporations.

Background

The Facts—Complete Immunity Preemption 

The Facts—Wyeth v. Levine

The Facts—Riegel v. Medtronic 

Timeline of Complete Immunity Preemption—The Evolution of Unauthorized Agency Preemption 

Diana Levine Testimony before the House Oversight and Government Reform Committee Hearing entitled: “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?” 

ResearchGet Out Of Jail Free: How the Bush Administration Helps Corporations Escape Accountability 

The Truth about Torts: Using Agency Preemption to Undercut Consumer Health and Safety, Center for Progressive Reform, Sept. 2007 

The Truth about Torts: Regulatory Preemption at the National Highway Transportation Safety Administration, Center for Progressive Reform, July 2008 

In Their Own Words

Quotes on Complete Immunity Preemption From the News Media

Quotes from Experts in Leading Medical Journals Highlights Dangers of Complete Immunity Preemption

Quotes from the Congressional Testimony of Dennis Quaid

Quotes from the Congressional Testimony of Leading Experts on FDA Complete Immunity Preemption


The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2010 AAJ